Deborah Assouan, Delphine Lebon, Amandine Charbonnier, Bruno Royer, Jean-Pierre Marolleau, et al.. Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease.
British Journal of Haematology, 2018, 181 (5), pp.687-689.
⟨10.1111/bjh.14679⟩.
⟨hal-03605027⟩